Harshbarger Benjamin 4
4 · CATABASIS PHARMACEUTICALS INC · Filed Jun 10, 2021
Insider Transaction Report
Form 4
Harshbarger Benjamin
Chief Legal Officer
Transactions
- Award
Stock Option (right to buy)
2021-06-08+200,000→ 200,000 totalExercise: $2.16Exp: 2031-06-07→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]The option is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of June 8, 2021 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.